188Re-PSMA-GCK01

N/A

Report date: 2025/11/20 16:04:31
NME

Base Information

Drug Name188Re-PSMA-GCK01
Drug Alias Name188Re-PSMA-GCK01188-Re-PSMA-GCK01[188Re]Re-PSMA-GCK01
ClassificationRadiation-emitting products > Nuclides > Rhenium > 188ReRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionProstate-Specific Membrane Antigen modulators
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHeidelberg University HospitalTelix Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHeidelberg University Hospital
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A